Established guidelines recommend biopsying small tumors of the kidney ahead of any procedure to ablate them. A new study confirms the validity of pursuing another pathway.
Is portable MRI suitable for finding abnormalities in the brains of patients receiving new amyloid-targeting therapy for Alzheimer’s disease? Clinical researchers are about to find out.
There were no statistical differences in overall complication rates between the traditional and expedited groups, but there were marked savings and shorter hospital stays.
When referring physicians agree with radiologists’ recommendations on the clinical necessity of follow-up imaging, three-quarters of patients go on to complete the additional exam.
After programming its EMR to automatically order ultrasound screenings for people at risk of abdominal aortic aneurysms (AAAs), a healthcare system saw a 540% spike in monthly screening exams for the condition over a six-year period.
Might mammography enhanced by contrast media prove a surer, faster way than other modalities—including digital breast tomosynthesis—to get to a definitive diagnosis for women with dense breast tissue? The American College of Radiology wants to know.
The adult brain may be more malleable than scientists previously thought, according to new research presented at the 35th European College of Neuropsychopharmacology.
Children are at heightened risk of major clinical depression when at least one parent has a history of the disorder. New research shows depression markers appearing on structural and functional brain MRI ahead of symptoms in these “familial risk” offspring from infancy through early adulthood.
An AI startup in the neuro-oncology space has received the government’s go-ahead to market software for analyzing certain fast-growing brain tumors on MRI.
"This was an unneeded burden, which was solely adding to the administrative hassles of medicine," said American Society of Nuclear Cardiology President Larry Phillips.